Effect of low- and high-glycemic load on circulating incretins in a randomized clinical trial.

PubWeight™: 0.84‹?›

🔗 View Article (PMC 3519963)

Published in Metabolism on September 07, 2012

Authors

Shauna S Runchey1, Liisa M Valsta, Yvonne Schwarz, Chiachi Wang, Xiaoling Song, Johanna W Lampe, Marian L Neuhouser

Author Affiliations

1: Department of Medicine, Division of Endocrinology, Metabolism and Nutrition, University of Washington, Seattle, WA 98195, USA.

Articles cited by this

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79

Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr (1981) 7.49

Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA (1997) 6.92

A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr (1990) 6.49

The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA (2002) 6.05

Comparisons of percentage body fat, body mass index, waist circumference, and waist-stature ratio in adults. Am J Clin Nutr (2008) 5.01

Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care (1997) 4.46

Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care (2008) 4.32

Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. J Clin Endocrinol Metab (2001) 3.09

Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. J Clin Endocrinol Metab (1986) 2.80

Lifestyle risk factors and new-onset diabetes mellitus in older adults: the cardiovascular health study. Arch Intern Med (2009) 2.72

Effects of a low-glycemic load diet on resting energy expenditure and heart disease risk factors during weight loss. JAMA (2004) 2.70

Glycemic index: overview of implications in health and disease. Am J Clin Nutr (2002) 2.43

Prospective study of dietary carbohydrates, glycemic index, glycemic load, and incidence of type 2 diabetes mellitus in middle-aged Chinese women. Arch Intern Med (2007) 2.31

Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance. Diabetes (2007) 2.19

The use of the glycemic index in predicting the blood glucose response to mixed meals. Am J Clin Nutr (1986) 2.03

Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down? Diabetologia (2010) 1.98

Glycemic index, glycemic load, and cereal fiber intake and risk of type 2 diabetes in US black women. Arch Intern Med (2007) 1.67

Carbohydrate and fiber recommendations for individuals with diabetes: a quantitative assessment and meta-analysis of the evidence. J Am Coll Nutr (2004) 1.53

Postprandial glucose, insulin, and incretin responses to grain products in healthy subjects. Am J Clin Nutr (2002) 1.38

Effect of protein, fat, carbohydrate and fibre on gastrointestinal peptide release in humans. Regul Pept (2008) 1.33

A low-glycemic index diet combined with exercise reduces insulin resistance, postprandial hyperinsulinemia, and glucose-dependent insulinotropic polypeptide responses in obese, prediabetic humans. Am J Clin Nutr (2010) 1.32

A low-glycemic load diet reduces serum C-reactive protein and modestly increases adiponectin in overweight and obese adults. J Nutr (2011) 1.15

Impact of cereal fibre on glucose-regulating factors. Diabetologia (2005) 1.15

Glucagon-like peptide analogues for type 2 diabetes mellitus: systematic review and meta-analysis. BMC Endocr Disord (2010) 1.14

Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose). Scand J Gastroenterol (1995) 1.09

Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance. Metabolism (2004) 1.07

Understanding "insulin resistance": both glucose resistance and insulin resistance are required to model human diabetes. Metabolism (1991) 1.00

Fat oxidation during exercise and satiety during recovery are increased following a low-glycemic index breakfast in sedentary women. J Nutr (2009) 0.94

Effects of variations in duodenal glucose load on glycaemic, insulin, and incretin responses in type 2 diabetes. Diabet Med (2012) 0.93

Effects of pre-meal versus post-meal administration of miglitol on plasma glucagon-like peptide-1 and glucosedependent insulinotropic polypeptide levels in healthy men. Endocr J (2010) 0.86

Metabolic effects of diets differing in glycaemic index depend on age and endogenous glucose-dependent insulinotrophic polypeptide in mice. Diabetologia (2009) 0.86

Glucagon-like peptide-1 (7-36) amide response to low versus high glycaemic index preloads in overweight subjects with and without type II diabetes mellitus. Eur J Clin Nutr (2007) 0.81

The effects of an alpha-glucoside hydrolase inhibitor on glycemia and the absorption of sucrose in man determined using a tracer method. Diabetes (1984) 0.79

Articles by these authors

Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. J Natl Cancer Inst (2013) 10.30

Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet (2003) 5.16

Antibiotic use in relation to the risk of breast cancer. JAMA (2004) 4.28

Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev (2006) 4.02

Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA (2004) 3.77

Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol (2009) 3.58

HER2 amplification: a potential mechanism of acquired resistance to EGFR inhibition in EGFR-mutant lung cancers that lack the second-site EGFRT790M mutation. Cancer Discov (2012) 3.04

PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet (2002) 2.81

DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem (2007) 2.65

Pooled results from 5 validation studies of dietary self-report instruments using recovery biomarkers for energy and protein intake. Am J Epidemiol (2014) 2.53

Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study. Ann Intern Med (2010) 2.48

Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS One (2008) 2.46

Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. Am J Clin Nutr (2010) 2.43

Protein intake and incident frailty in the Women's Health Initiative observational study. J Am Geriatr Soc (2010) 2.28

Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. J Urol (2007) 2.24

Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med (Maywood) (2005) 2.22

Changes in diet, physical activity, and supplement use among adults diagnosed with cancer. J Am Diet Assoc (2003) 2.11

Circulating long-chain ω-3 fatty acids and incidence of congestive heart failure in older adults: the cardiovascular health study: a cohort study. Ann Intern Med (2011) 2.06

Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev (2009) 2.06

Evaluation and comparison of food records, recalls, and frequencies for energy and protein assessment by using recovery biomarkers. Am J Epidemiol (2011) 2.04

Nightshift work and genome-wide DNA methylation. Chronobiol Int (2014) 2.01

Biomarker-calibrated energy and protein consumption and increased cancer risk among postmenopausal women. Am J Epidemiol (2009) 1.98

Dietary acculturation: applications to nutrition research and dietetics. J Am Diet Assoc (2002) 1.95

Fruit and vegetable intake and risk of breast cancer by hormone receptor status. J Natl Cancer Inst (2013) 1.94

Food nutrition label use is associated with demographic, behavioral, and psychosocial factors and dietary intake among African Americans in North Carolina. J Am Diet Assoc (2005) 1.92

Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma. Cancer Res (2013) 1.88

Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complement Med (2002) 1.85

Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings. J Natl Cancer Inst (2006) 1.85

A mathematical model gives insights into nutritional and genetic aspects of folate-mediated one-carbon metabolism. J Nutr (2006) 1.82

Plasma omega-3 fatty acids and incident diabetes in older adults. Am J Clin Nutr (2011) 1.79

"Frontal" behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness. J Neuropsychiatry Clin Neurosci (2010) 1.76

Cruciferous vegetable feeding alters UGT1A1 activity: diet- and genotype-dependent changes in serum bilirubin in a controlled feeding trial. Cancer Prev Res (Phila) (2009) 1.76

Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial. Am J Epidemiol (2011) 1.71

Exercise effect on weight and body fat in men and women. Obesity (Silver Spring) (2007) 1.68

Challenges assessing clinical endpoints in early Huntington disease. Mov Disord (2010) 1.66

Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidemiol (2008) 1.66

FDR-controlling testing procedures and sample size determination for microarrays. Stat Med (2005) 1.64

No evidence of an association of JC virus and colon neoplasia. Cancer Epidemiol Biomarkers Prev (2004) 1.62

Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors. Breast Cancer Res Treat (2008) 1.60

Nutrient intake and anemia risk in the women's health initiative observational study. J Am Diet Assoc (2011) 1.60

Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes. Am J Clin Nutr (2010) 1.55

Association of plasma phospholipid long-chain ω-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study. Circulation (2012) 1.54

TGF-beta receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a beta-catenin-independent pathway. Gastroenterology (2009) 1.50

Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial. Cancer Res (2012) 1.50

Brassica vegetables and prostate cancer risk: a review of the epidemiological evidence. Nutr Cancer (2002) 1.46

Earliest functional declines in Huntington disease. Psychiatry Res (2010) 1.45

Pooled results from 5 validation studies of dietary self-report instruments using recovery biomarkers for potassium and sodium intake. Am J Epidemiol (2015) 1.45

Measuring the glycemic index of foods: interlaboratory study. Am J Clin Nutr (2008) 1.44

Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults: a cohort study. Ann Intern Med (2013) 1.43

Soy protein isolates of varying isoflavone content do not adversely affect semen quality in healthy young men. Fertil Steril (2009) 1.42

Is olestra consumption associated with changes in dietary intake, serum lipids, and body weight? Nutrition (2003) 1.41

Cancer prevention behaviors and socioeconomic status among Hispanics and non-Hispanic whites in a rural population in the United States. Cancer Causes Control (2002) 1.41

A cross-sectional study of equol producer status and self-reported vasomotor symptoms. Menopause (2015) 1.39

Human gut bacterial communities are altered by addition of cruciferous vegetables to a controlled fruit- and vegetable-free diet. J Nutr (2009) 1.37

Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2004) 1.35

Optimization of terminal restriction fragment polymorphism (TRFLP) analysis of human gut microbiota. J Microbiol Methods (2006) 1.34

Comparing indices of diet quality with chronic disease mortality risk in postmenopausal women in the Women's Health Initiative Observational Study: evidence to inform national dietary guidance. Am J Epidemiol (2014) 1.34

Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidemiol (2008) 1.34

Participant characteristics associated with errors in self-reported energy intake from the Women's Health Initiative food-frequency questionnaire. Am J Clin Nutr (2002) 1.33

Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial. Am J Epidemiol (2010) 1.33

Biomarker-calibrated dietary energy and protein intake associations with diabetes risk among postmenopausal women from the Women's Health Initiative. Am J Clin Nutr (2011) 1.31

The 2011-2016 Transdisciplinary Research on Energetics and Cancer (TREC) initiative: rationale and design. Cancer Causes Control (2013) 1.26

Recreational physical activity, body mass index, and survival in women with colorectal cancer. Cancer Causes Control (2012) 1.26

Nutrition and physical activity cancer prevention guidelines, cancer risk, and mortality in the women's health initiative. Cancer Prev Res (Phila) (2014) 1.26

Postdiagnosis diet quality, the combination of diet quality and recreational physical activity, and prognosis after early-stage breast cancer. Cancer Causes Control (2011) 1.25

Postdiagnosis diet quality is inversely related to a biomarker of inflammation among breast cancer survivors. Cancer Epidemiol Biomarkers Prev (2010) 1.25

Leptin concentrations, leptin receptor polymorphisms, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev (2007) 1.25

Labelling the salt content in foods: a useful tool in reducing sodium intake in Finland. Public Health Nutr (2007) 1.25

An overview of the health effects of isoflavones with an emphasis on prostate cancer risk and prostate-specific antigen levels. J AOAC Int (2006) 1.24

Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls. J Nutr (2006) 1.24

Genome-wide association of body fat distribution in African ancestry populations suggests new loci. PLoS Genet (2013) 1.24

Erythrocyte fatty acids and breast cancer risk: a case-control study in Shanghai, China. Am J Clin Nutr (2007) 1.22

A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev (2009) 1.22

Food sources of individual plasma phospholipid trans fatty acid isomers: the Cardiovascular Health Study. Am J Clin Nutr (2010) 1.22

Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studies. Am J Clin Nutr (2012) 1.21

Dietary and other risk factors in women having fibrocystic breast conditions with and without concurrent breast cancer: a nested case-control study in Shanghai, China. Int J Cancer (2005) 1.19

Effect of a 12-month exercise intervention on patterns of cellular proliferation in colonic crypts: a randomized controlled trial. Cancer Epidemiol Biomarkers Prev (2006) 1.17

Demographic, anthropometric, and lifestyle factors and dietary intakes in relation to daidzein-metabolizing phenotypes among premenopausal women in the United States. Am J Clin Nutr (2008) 1.17

Transition of a clinical trial into translational research: the prostate cancer prevention trial experience. Cancer Prev Res (Phila) (2010) 1.17

Obsessive and compulsive symptoms in prediagnosed Huntington's disease. J Clin Psychiatry (2008) 1.17

Fatty acid consumption and risk of fracture in the Women's Health Initiative. Am J Clin Nutr (2010) 1.16

Obesity and the risk for premenopausal and postmenopausal breast cancer. Cancer Prev Res (Phila) (2012) 1.16

Self-paced timing detects and tracks change in prodromal Huntington disease. Neuropsychology (2010) 1.16

Specialty supplements and breast cancer risk in the VITamins And Lifestyle (VITAL) Cohort. Cancer Epidemiol Biomarkers Prev (2010) 1.15

Total mortality risk in relation to use of less-common dietary supplements. Am J Clin Nutr (2010) 1.15

Validation of a soy food-frequency questionnaire and evaluation of correlates of plasma isoflavone concentrations in postmenopausal women. Am J Clin Nutr (2003) 1.15

A low-glycemic load diet reduces serum C-reactive protein and modestly increases adiponectin in overweight and obese adults. J Nutr (2011) 1.15

Associations between healthy eating patterns and immune function or inflammation in overweight or obese postmenopausal women. Am J Clin Nutr (2007) 1.14

A case-control study of risk factors for fibrocystic breast conditions: Shanghai Nutrition and Breast Disease Study, China, 1995-2000. Am J Epidemiol (2004) 1.12

Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial. Am J Epidemiol (2011) 1.12

Effects of weight loss on serum vitamin D in postmenopausal women. Am J Clin Nutr (2011) 1.12

Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity. J Natl Cancer Inst (2013) 1.11